{"transactions":[{"id":814126,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T21:03:21.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":280,"price":21.3612,"value":5981.136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27422,"source":{"system":"sec-edgar","filing":"0001919246-26-000055","document":"wk-form4_1775509399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000191924626000055/wk-form4_1775509399.xml","form_type":"4"}},{"id":814125,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T21:03:21.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":310,"price":20.5126,"value":6358.906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27702,"source":{"system":"sec-edgar","filing":"0001919246-26-000055","document":"wk-form4_1775509399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000191924626000055/wk-form4_1775509399.xml","form_type":"4"}},{"id":822400,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:44:43.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":19108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"From June 18, 2024 to July 7, 2025, the reporting person  filed multiple Form 4s relating to shares of common stock, par value $0.0001 per share (\"Common Stock\") of Pelthos Therapeutics Inc. (the \"Issuer\"), issuable upon settlement of restricted stock units of the Issuer (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the \"2023 Plan\"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4s filed by the reporting person (the \"Original Form 4s\").  This Form 4 amendment (this \"Amendment\") is being filed to amend the Original Form 4s in order to report the grant of such RSUs in Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."}],"balance_after":28012,"source":{"system":"sec-edgar","filing":"0001919246-26-000045","document":"wk-form4a_1775079878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000191924626000045/wk-form4a_1775079878.xml","form_type":"4/A","original_submission_date":"2025-07-07"}},{"id":822399,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:44:43.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":2454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"From June 18, 2024 to July 7, 2025, the reporting person  filed multiple Form 4s relating to shares of common stock, par value $0.0001 per share (\"Common Stock\") of Pelthos Therapeutics Inc. (the \"Issuer\"), issuable upon settlement of restricted stock units of the Issuer (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the \"2023 Plan\"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4s filed by the reporting person (the \"Original Form 4s\").  This Form 4 amendment (this \"Amendment\") is being filed to amend the Original Form 4s in order to report the grant of such RSUs in Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amounts have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025."}],"balance_after":8904,"source":{"system":"sec-edgar","filing":"0001919246-26-000045","document":"wk-form4a_1775079878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000191924626000045/wk-form4a_1775079878.xml","form_type":"4/A","original_submission_date":"2025-07-07"}},{"id":822398,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:44:43.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"From June 18, 2024 to July 7, 2025, the reporting person  filed multiple Form 4s relating to shares of common stock, par value $0.0001 per share (\"Common Stock\") of Pelthos Therapeutics Inc. (the \"Issuer\"), issuable upon settlement of restricted stock units of the Issuer (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the \"2023 Plan\"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4s filed by the reporting person (the \"Original Form 4s\").  This Form 4 amendment (this \"Amendment\") is being filed to amend the Original Form 4s in order to report the grant of such RSUs in Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amounts have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025."}],"balance_after":6450,"source":{"system":"sec-edgar","filing":"0001919246-26-000045","document":"wk-form4a_1775079878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000191924626000045/wk-form4a_1775079878.xml","form_type":"4/A","original_submission_date":"2025-07-07"}},{"id":1091050,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-07-08T01:41:33.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":58230,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years."}],"balance_after":58230,"derivative":{"exercise_price":13.5,"exercise_date":"2026-07-02","expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":58230},"source":{"system":"sec-edgar","filing":"0001753926-25-001103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000175392625001103/ownership.xml","form_type":"4"}},{"id":1091049,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-07-08T01:41:33.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":19108,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025."}],"balance_after":28012,"derivative":{"exercise_price":13.5,"exercise_date":"2026-07-02","expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":19108},"source":{"system":"sec-edgar","filing":"0001753926-25-001103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000175392625001103/ownership.xml","form_type":"4"}},{"id":1363117,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-11-15T21:20:59.000Z","date":"2024-11-13","kind":"grant","planned":false,"acquired":true,"shares":24533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 13, 2024, the Reporting Person was granted restricted stock units to purchase 24,533 shares of common stock at an exercise price of $0.64 per share, which shall vest on a quarterly basis over a period of six (6) quarters."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2024, the Reporting Person was granted restricted stock units to purchase 24,533 shares of common stock at an exercise price of $0.64 per share, which shall vest on a quarterly basis over a period of six (6) quarters."}],"balance_after":116098,"derivative":{"exercise_price":0.64,"expiration_date":"2024-11-13","underlying":"Common Stock","underlying_shares":24533},"source":{"system":"sec-edgar","filing":"0001753926-24-001949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000175392624001949/ownership.xml","form_type":"4"}},{"id":1406313,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-16T20:56:55.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":10400,"price":0.9447,"value":9824.88,"ownership":{"direct":false,"nature":"Jointly held with spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price represents the weighted average price of the shares purchased ranging from $0.9206 to $0.9554 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":91565,"source":{"system":"sec-edgar","filing":"0001753926-24-001578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000175392624001578/ownership.xml","form_type":"4"}},{"id":1474394,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-19T00:02:38.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":64498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 14, 2024, the Reporting Person was granted restricted stock units to purchase 64,498 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, the Reporting Person was granted restricted stock units to purchase 64,498 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years."}],"balance_after":81165,"derivative":{"exercise_price":1.3,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":64498},"source":{"system":"sec-edgar","filing":"0001753926-24-001131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772168/000175392624001131/ownership.xml","form_type":"4"}},{"id":2397588,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:49:23.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":1838,"price":17.63,"value":32403.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":130264,"source":{"system":"sec-edgar","filing":"0001062993-22-004326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004326/form4.xml","form_type":"4"}},{"id":2397587,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:49:23.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":4462,"price":17.63,"value":78665.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":132102,"source":{"system":"sec-edgar","filing":"0001062993-22-004326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004326/form4.xml","form_type":"4"}},{"id":2397586,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:49:23.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":6256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 6,256 performance share units granted in the issuer's two prior fiscal years."}],"balance_after":136564,"source":{"system":"sec-edgar","filing":"0001062993-22-004326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004326/form4.xml","form_type":"4"}},{"id":2397585,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:49:23.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":36750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":130308,"source":{"system":"sec-edgar","filing":"0001062993-22-004326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004326/form4.xml","form_type":"4"}},{"id":2757333,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-05T23:07:28.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":3119,"price":23.38,"value":72922.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":93558,"source":{"system":"sec-edgar","filing":"0001192482-21-000322","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000322/edgar.xml","form_type":"4"}},{"id":2862828,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:13:55.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":1542,"price":25.95,"value":40014.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":96677,"source":{"system":"sec-edgar","filing":"0001192482-21-000146","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000146/edgar.xml","form_type":"4"}},{"id":2862827,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:13:55.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":758,"price":25.95,"value":19670.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":98219,"source":{"system":"sec-edgar","filing":"0001192482-21-000146","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000146/edgar.xml","form_type":"4"}},{"id":2898998,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-22T21:03:12.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":2187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 2,187 performance share units granted in a prior year."}],"balance_after":98977,"source":{"system":"sec-edgar","filing":"0001192482-21-000092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000092/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2898997,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-22T21:03:12.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":36960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":96790,"source":{"system":"sec-edgar","filing":"0001192482-21-000092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000092/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900527,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T21:32:38.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":105600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":105600,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":105600},"source":{"system":"sec-edgar","filing":"0001192482-21-000088","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000088/edgar.xml","form_type":"4"}},{"id":2900526,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:32:38.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":2187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 2,187 performance share units granted in a prior year."}],"balance_after":98977,"source":{"system":"sec-edgar","filing":"0001192482-21-000088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000088/edgar.xml","form_type":"4"}},{"id":2900525,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:32:38.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":36960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":96790,"source":{"system":"sec-edgar","filing":"0001192482-21-000088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000088/edgar.xml","form_type":"4"}},{"id":3182775,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T20:16:00.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":2920,"price":15.49,"value":45230.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":59830,"source":{"system":"sec-edgar","filing":"0001192482-20-000272","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000272/edgar.xml","form_type":"4"}},{"id":3284313,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T21:11:36.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":22500,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001192482-20-000139","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000139/edgar.xml","form_type":"4"}},{"id":3284312,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-07T21:11:36.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":62750,"source":{"system":"sec-edgar","filing":"0001192482-20-000139","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000139/edgar.xml","form_type":"4"}},{"id":3568109,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-04-02T20:15:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on April 1, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer."}],"balance_after":85000,"derivative":{"exercise_price":15.12,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001192482-19-000182","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000182/edgar.xml","form_type":"4"}},{"id":3568108,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53559,"kind":"person","name":"Malamut Richard","position":1,"cik":"0001772168","reported_name":"Malamut Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-02T20:15:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on April 1, 2020, and the balance of the restricted stock units vest in equal annual installments (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001192482-19-000182","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000182/edgar.xml","form_type":"4"}}]}